A Phase 1,Open -Label Study to Assess the Absorption, Metabolism and Excretion of 14C-OPS-2071 Following a Single Oral Dose to Healthy Male Japanese Subjects

NCT02440633 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

8

Enrollment

INDUSTRY

Sponsor class

Conditions

Bacterial Enteritis

Interventions

DRUG: 14C-OPS-2071

Sponsor

Otsuka Pharmaceutical Co., Ltd.